Risk Factors and Outcomes of Multidrug-resistant Pseudomonas aeruginosa in Kelantan, Malaysia: A Multicenter Case–control Study
Background: Increasing trend and spread of multidrug-resistant Pseudomonas aeruginosa (MDR-PA) in clinical settings is a great challenge in managing patients with infections caused by this pathogen. Objective: To determine the risk factors and outcomes of MDR-PA acquisition in the northeastern state...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Saudi Journal of Medicine and Medical Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/sjmms.sjmms_429_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849717400143921152 |
|---|---|
| author | Siti Norfairuz Md. Salim Nurul Izzah Md Din Rosnita Rashid Sharifah Aisyah Sayed Hitam Zakuan Zainy Deris |
| author_facet | Siti Norfairuz Md. Salim Nurul Izzah Md Din Rosnita Rashid Sharifah Aisyah Sayed Hitam Zakuan Zainy Deris |
| author_sort | Siti Norfairuz Md. Salim |
| collection | DOAJ |
| description | Background:
Increasing trend and spread of multidrug-resistant Pseudomonas aeruginosa (MDR-PA) in clinical settings is a great challenge in managing patients with infections caused by this pathogen.
Objective:
To determine the risk factors and outcomes of MDR-PA acquisition in the northeastern state of Malaysia. In addition, this study also reported on the susceptibility pattern and common resistant genes among MDR-PA.
Materials and Methods:
MDR-PA isolates obtained between March 2021 and February 2022 from all four major hospitals in the state of Kelantan, Malaysia, were submitted for susceptibility and resistant genes identification. The clinical data of the patients with MDR-PA were retrospectively reviewed. The risk factors and outcomes of MDR-PA acquired patients were analyzed by comparing with patients who acquired susceptible-PA while admitted to the same hospital during the study time.
Results:
A total of 100 MDR-PA and 100 susceptible-PA cases were included. Ceftolozane–tazobactam was susceptible in 41.3% of MDR-PA compared to only 4%–8% with other β-lactams. About half (46%) of the MDR-PA isolates harbored the bla-NDM-1 gene, but none had the bla-OXA-48 gene. Factors independently associated with MDR-PA acquisitions were age (OR: 1.02; P = 0.028), genitourinary disorder (OR: 6.89; P = 0.001), and central venous catheter (OR: 3.18; P = 0.001). In addition, MDR-PA acquisitions were found to be associated with antimicrobial treatment failure (41.1% vs. 25.0%; P = 0.001) and mortality (40.0% versus 6.0%; P <0.001).
Conclusion:
Most of the MDR-PA strains in Kelantan tertiary hospitals harbored the bla-NDM-1 gene, which is easily transmissible and can lead to an outbreak. Nonetheless, a significant number of the MDR-PA isolates were still susceptible to ceftolozane–tazobactam. |
| format | Article |
| id | doaj-art-2c6ff7b04df140ac896d0ea42a7ad3b4 |
| institution | DOAJ |
| issn | 1658-631X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Saudi Journal of Medicine and Medical Sciences |
| spelling | doaj-art-2c6ff7b04df140ac896d0ea42a7ad3b42025-08-20T03:12:40ZengWolters Kluwer Medknow PublicationsSaudi Journal of Medicine and Medical Sciences1658-631X2025-01-01131182510.4103/sjmms.sjmms_429_24Risk Factors and Outcomes of Multidrug-resistant Pseudomonas aeruginosa in Kelantan, Malaysia: A Multicenter Case–control StudySiti Norfairuz Md. SalimNurul Izzah Md DinRosnita RashidSharifah Aisyah Sayed HitamZakuan Zainy DerisBackground: Increasing trend and spread of multidrug-resistant Pseudomonas aeruginosa (MDR-PA) in clinical settings is a great challenge in managing patients with infections caused by this pathogen. Objective: To determine the risk factors and outcomes of MDR-PA acquisition in the northeastern state of Malaysia. In addition, this study also reported on the susceptibility pattern and common resistant genes among MDR-PA. Materials and Methods: MDR-PA isolates obtained between March 2021 and February 2022 from all four major hospitals in the state of Kelantan, Malaysia, were submitted for susceptibility and resistant genes identification. The clinical data of the patients with MDR-PA were retrospectively reviewed. The risk factors and outcomes of MDR-PA acquired patients were analyzed by comparing with patients who acquired susceptible-PA while admitted to the same hospital during the study time. Results: A total of 100 MDR-PA and 100 susceptible-PA cases were included. Ceftolozane–tazobactam was susceptible in 41.3% of MDR-PA compared to only 4%–8% with other β-lactams. About half (46%) of the MDR-PA isolates harbored the bla-NDM-1 gene, but none had the bla-OXA-48 gene. Factors independently associated with MDR-PA acquisitions were age (OR: 1.02; P = 0.028), genitourinary disorder (OR: 6.89; P = 0.001), and central venous catheter (OR: 3.18; P = 0.001). In addition, MDR-PA acquisitions were found to be associated with antimicrobial treatment failure (41.1% vs. 25.0%; P = 0.001) and mortality (40.0% versus 6.0%; P <0.001). Conclusion: Most of the MDR-PA strains in Kelantan tertiary hospitals harbored the bla-NDM-1 gene, which is easily transmissible and can lead to an outbreak. Nonetheless, a significant number of the MDR-PA isolates were still susceptible to ceftolozane–tazobactam.https://journals.lww.com/10.4103/sjmms.sjmms_429_24bla-ndm-1ceftolozane-tazobactammalaysiaoutcomespseudomonas aeruginosarisk factors |
| spellingShingle | Siti Norfairuz Md. Salim Nurul Izzah Md Din Rosnita Rashid Sharifah Aisyah Sayed Hitam Zakuan Zainy Deris Risk Factors and Outcomes of Multidrug-resistant Pseudomonas aeruginosa in Kelantan, Malaysia: A Multicenter Case–control Study Saudi Journal of Medicine and Medical Sciences bla-ndm-1 ceftolozane-tazobactam malaysia outcomes pseudomonas aeruginosa risk factors |
| title | Risk Factors and Outcomes of Multidrug-resistant Pseudomonas aeruginosa in Kelantan, Malaysia: A Multicenter Case–control Study |
| title_full | Risk Factors and Outcomes of Multidrug-resistant Pseudomonas aeruginosa in Kelantan, Malaysia: A Multicenter Case–control Study |
| title_fullStr | Risk Factors and Outcomes of Multidrug-resistant Pseudomonas aeruginosa in Kelantan, Malaysia: A Multicenter Case–control Study |
| title_full_unstemmed | Risk Factors and Outcomes of Multidrug-resistant Pseudomonas aeruginosa in Kelantan, Malaysia: A Multicenter Case–control Study |
| title_short | Risk Factors and Outcomes of Multidrug-resistant Pseudomonas aeruginosa in Kelantan, Malaysia: A Multicenter Case–control Study |
| title_sort | risk factors and outcomes of multidrug resistant pseudomonas aeruginosa in kelantan malaysia a multicenter case control study |
| topic | bla-ndm-1 ceftolozane-tazobactam malaysia outcomes pseudomonas aeruginosa risk factors |
| url | https://journals.lww.com/10.4103/sjmms.sjmms_429_24 |
| work_keys_str_mv | AT sitinorfairuzmdsalim riskfactorsandoutcomesofmultidrugresistantpseudomonasaeruginosainkelantanmalaysiaamulticentercasecontrolstudy AT nurulizzahmddin riskfactorsandoutcomesofmultidrugresistantpseudomonasaeruginosainkelantanmalaysiaamulticentercasecontrolstudy AT rosnitarashid riskfactorsandoutcomesofmultidrugresistantpseudomonasaeruginosainkelantanmalaysiaamulticentercasecontrolstudy AT sharifahaisyahsayedhitam riskfactorsandoutcomesofmultidrugresistantpseudomonasaeruginosainkelantanmalaysiaamulticentercasecontrolstudy AT zakuanzainyderis riskfactorsandoutcomesofmultidrugresistantpseudomonasaeruginosainkelantanmalaysiaamulticentercasecontrolstudy |